Complementary and alternative medicine in lung cancer patients: A neglected phenomenon?

Frontiers of Radiation Therapy and Oncology

Volumn 42, Issue , 2010, Pages 198-205

  Micke, Oliver ^a,b,g   Buntzel J ^c,g   Kisters, K ^d,g   Schafer U ^e,g   Micke, P ^f   Mucke R ^e,g  

^a FRANZISKUS HOSPITAL   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c Sudharz Hospital   (Germany)

^d ST ANNA HOSPITAL   (Germany)

^e LIPPE HOSPITAL   (Germany)

^f UPPSALA UNIVERSITY   (Sweden)

^g Electrolytes in Radiation Oncology AKTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SELENIUM; THYMUS EXTRACT; TRACE ELEMENT;

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; FEMALE; HOMEOPATHY; HUMAN; LUNG NON SMALL CELL CANCER; MALE; OUTCOME ASSESSMENT; PHYSIOTHERAPY; PRIORITY JOURNAL; RELIGION; VISCUM ALBUM; VITAMIN SUPPLEMENTATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COMPLEMENTARY THERAPIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING;

EID: 77949383750     PISSN: 00719676     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000262477     Document Type: Article

References (39)

1. Robert Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. (eds): Krebs in Deutschland 2003-2004. Häufigkeiten und Trends, ed 6, revised. Berlin, 2008.
2. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC: Use of alternative medicine by women with earlystage breast cancer. N Engl J Med 1999;340:1733-1739.
3. Ernst E, Cassileth BR: The prevalence of complementary/ alternative medicine in cancer: a systematic review. Cancer 1998;83:777-782.
4. Micke O, Büntzel J: Complementary and alternative medicine in tumor patients. A dilemma in modern oncology. Onkologe 2008;14:73-80.
5. Risberg T, Kolstad A, Bremnes Y, Holte H, Wist EA, Mella O, Klepp O, Wilsgaard T, Cassileth BR: Knowledge of and attitudes toward complementary and alternative therapies; a national multicentre study of oncology professionals in Norway. Eur J Cancer 2004;40:529-535.
6. Risberg T, Lund E, Wist E: Use of non-proven therapies: differences in attitudes between Norwegian patients with non-malignant disease and patients suffering from cancer. Acta Oncol 1995; 34:893-898.
7. Burstein HJ: Discussing complementary therapies with cancer patients: what should we be talking about? J Clin Oncol. 2000;18:2501-2504.
8. Cassileth BR, Deng GE, Gomez JE, Johnstone PA, Kumar N, Vickers AJ: Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines, ed 2. Chest. 2007;132(3 suppl):340S-354S.
9. NCCAM: What is complementary and alternative medicine (CAM)? National Center for Complementary and Alternative Medicine (NCCAM), National Institutes of Health, 2009. http://nccam. nih.gov/health/whatiscam/overview.htm.
10. Schönekaes K, Micke O, Mücke R, Büntzel J, Glatzel M, Bruns F, Kisters K: Use of complementary/ alternative therapy methods by patients with breast cancer. Forsch Komplementarmed Klass Naturheilkd 2003;10:304-308.
11. Cassileth BR, Deng G: Complementary and alternative therapies for cancer. Oncologist 2004;9:80-89.
12. Büntzel J, Glatzel M, Bruns F, KistersK, Micke O, Mücke R: Selenium supplementation in head and neck surgery. Trace Elem Electrolytes 2008;25:221.
13. Ernst E, Cassileth BR: How useful are unconventional cancer treatments? Eur J Cancer 1999;35: 1608-1613.
14. Micke O, Büntzel J, Bruns F, Glatzel M, Hunger R, Kisters K, Mücke R: Clinical elementology in oncology: experiences and proposals from Germany. Trace Elem Electrolytes 2008;25:221.
15. Barnes PM, Bloom B, Nahin RL: Complementary and Alternative Medicine Use Among Adults and Children: United States, 2007. National Health Statistics Reports; No 12. Hyattsville, National Center for Health Statistics, 2008.
16. Micke O, Mücke R, Schönekaes K, Büntzel J: Complementary and alternative medicine in radiotherapy patients-more harm than expected? In regard to D'Amico et al: Self-administration of untested medical therapy for treatment of prostate cancer can lead to clinically significant adverse events. Int J Radiat Oncol Biol Phys 2002; 54:1311-1313.
17. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary S: Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000; 8:2505-2514.
18. Söllner W, Maislinger S, DeVries A, Steixner E, Rumpold G, Lukas P: Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey. Cancer 2000;89:873-880.
19. Vapiwala N, Mick R, Hampshire MK, Metz JM, DeNittis AS: Patient initiation of complementary and alternative medical therapies (CAM) following cancer diagnosis. Cancer J 2006;12:467-474.
20. Micke O, Bruns F, Glatzel M, Schönekaes K, Micke P, Mücke R, Büntzel J: Predictive factors for the use of complementary and alternative medicine (CAM) in radiation oncology. Eur J Integ Med 2009;1:22-30.
21. Boon H, Stewart M, Kennard MA, Gray R, Sawka C, Brown JB, McWilliam C, Gavin A, Baron RA, Aaron D, Haines-Kamka T: Use of complementary/ alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol 2000;18:2515-2521.
22. Wells M, Sarna L, Cooley ME, Brown JK, Chernecky C, Williams RD, Padilla G, Danao LL: Use of complementary and alternative medicine therapies to control symptoms in women living with lung cancer. Cancer Nurs 2007;30:45-55.
23. Bass DB, Stewart-Sicking J: Christian Spirituality in Europe and North America since 1700-SO. Blackwell Companion to Christian Spirituality 2007;139-155.
24. Sloan RP: Religion, medical science, and the rise of subjectivity. Eur J Integ Med 2009;1:1-7.
25. Micke O, Büntzel J, Mücke R, Glatzel M: Spirituality in radiation oncology-from belief to bedside: a new focus for research? Eur J Integ Med 2008;1(suppl):11.
26. Boon H, Brown J, Gavin A: What are the experiences of women with breast cancer as they decide whether to use complementary/alternative medicine? West J Med 2000;173:39.
27. Astin JA: Why patients use alternative medicine: results of a national study. JAMA 1998;279:1548-1553.
28. Verhoef MJ, Hagen N, Pelletier G, Forsyth P: Alternative therapy use in neurologic diseases: use in brain tumor patients. Neurology 1999;52: 617-622.
29. Ernst E: Intangible risks of complementary and alternative medicine. J Clin Oncol 2001;19:2365-2366.
30. Jungi WF: Risks of alternative cancer treatment. Onkologie 1986;9:231-234.
31. Markman M: Safety issues in using complementary and alternative medicine. J Clin Oncol 2002; 20:39S-41S.
32. Lamson DW, Brignall MS: Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Altern Med Rev 1999;4:304-329.
33. Lamson DW, Brignall MS: Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Altern Med Rev 1999;4:304-329.
34. Labriola D, Livingston R: Possible interactions between dietary antioxidants and chemotherapy. Oncology (Huntingt) 1999;13:1003-1008
35. Lagman R, Walsh D: Dangerous nutrition? Calcium, vitamin D, and shark cartilage nutritional supplements and cancer-related hypercalcemia. Support Care Cancer 2003;11:232-235.
36. Snodgrass SR: Vitamin neurotoxicity. Mol Neurobiol 1992;6:41-73.
37. Ernst E: Harmless herbs? A review of the recent literature. Am J Med 1998;104:170-178.
38. Schmidt K, Ernst E: Assessing websites on complementary and alternative medicine for cancer. Ann Oncol 2004;15:733-742.
39. Bruns F, Mücke R, Büntzel J, Kisters K, Micke O: Trace elements supplementation in radiation oncology: an empirical study assessing the quality of health information for consumers on the World Wide Web in Germany. Trace Elem Electrolytes 2005;22:311-315.